Status:
COMPLETED
Interstitial Lung Disease Associated
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Interstitial Lung Disease
Eligibility:
All Genders
18-85 years
Brief Summary
This single-center, retrospective cohort study was conducted to determine whether ANCA-ILD spectrum share the same clinical manifestations and outcome with CTD feature disease spectrum.
Detailed Description
We retrospectively reviewed patients who had been diagnosed with interstitial pneumonia during outpatient or hospitalization at Peking Union Medical College Hospital (PUMCH) between January 2012 and D...
Eligibility Criteria
Inclusion
- Males and females
- Aged from 18 to 85 years with informed consent
- Have a diagnosis of ILD based on clinical symptoms and radiologic features, with or without histopathologic results
Exclusion
- ILD induced by drug, environment, or occupational exposure
- Hypersensitivity pneumonitis and sarcoidosis
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06007040
Start Date
January 1 2012
End Date
December 1 2021
Last Update
August 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730